Nirsevimab Effectiveness Against Severe Respiratory Syncytial Virus Infection in the Primary Care Setting. Lopez-Lacort M, Munoz-Quiles C, Mira-Iglesias A, Xavier Lopez-Labrador F, et al. Pediatrics 2025;155:e2024066393.

Read + Share

Amedeo Smart

Independent Medical Education

Lopez-Lacort M, Munoz-Quiles C, Mira-Iglesias A, Xavier Lopez-Labrador F, et al. Nirsevimab Effectiveness Against Severe Respiratory Syncytial Virus Infection in the Primary Care Setting. Pediatrics 2025;155:e2024066393.
PMID: 39363387